Posted on Nov 14, 2021, 1:12 PMUpdated Nov 14, 2021, 1:15 PM
Mergers and acquisitions in private equity in Europe are accelerating. In the wake of Eurazeo, the heavyweight EQT is strengthening in health. The Swedish Wallenberg family fund has announced the acquisition of LSP, one of the oldest Dutch investment companies in new life sciences.
At the head of more than 70 billion euros in assets, the fund led by Christian Sinding is getting its hands on a new line of venture capital investment and 2.2 billion euros in additional assets, against a cash payment of 475 million euros. “This is a very strategic acquisition for us,” said Michael Bauer, partner and co-head of EQT’s healthcare division. Until now, EQT has only invested in mature health companies, such as in France in April with Cerba laboratories for 4.5 billion euros. “The acquisition of LSP will allow us to deploy capital in innovative companies in the sector. They require a different scientific risk assessment than established companies, ”added the partner.